Abiopharma

🔍 Finegan Michael (Executive)

Company: Orthofix Medical Inc. (OFIX)

Report Date: 2026-06-10

Detailed Transactions and Holdings:

• Acquired 20,721 shares of Common Stock (Direct)
  Date: 2026-06-10 | Code: A | equity_swap_involved: false | shares_owned_after: 81,617.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Represents an award of deferred stock units that vest in full on the first anniversary of the grant date, subject to the reporting person's service through such date. Each deferred stock unit represents a contingent right to receive one share of common stock of the issuer. Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer.
• F2: Includes 55,805 previously reported deferred stock units and an aggregate of 3,505 shares acquired under Orthofix's Stock Purchase Plan ("Orthofix's SPP") on 10/31/2025 and 4/30/2026. Orthofix's SPP is a "Stock Purchase Plan" as defined in Rule 16b-3(b)(5), and share acquisitions under the plan are exempt from Section 16(b).